Tag: Canada
Zydus, Formycon forge exclusive deal to license & supply Keytruda biosimilar...
The BLA application is expected to be submitted to the USFDA in the near future and is aimed at making immunotherapy affordable and accessible to patients in need
The Medtech Conference Canada to feature a panel discussion on Indian...
Experts to discuss expanding opportunity & potential for value accretive partnerships
Biocon Biologics secures market entry for its Bmab 1200 Biosimilar in...
Under the terms of this settlement agreement, Biocon Biologics has resolved patent disputes with Janssen to secure market entry dates in Europe, the UK, Canada, and Japan
Lupin receives Health Canada approval for biosimilar Pegfilgrastim
This product will be marketed under the brand name Armlupeg® and manufactured at Lupin’s Biotech facility at Pune, India
OPPI welcomes Indian govt’s move to waive off local clinical trials...
This will be applicable to a few select drugs already approved in well-regulated markets like the USA, UK, Japan, Australia, Canada, and the EU
Inviting your participation in the upcoming India MedTech Handbook 2024
The second edition of India MedTech Handbook, “From Innovation to Expansion: Charting the Rise of India's MedTech Ecosystem” will be launched on October 15-17, 2024 in Toronto, Canada
Lupin launches Rymti biosimilar for chronic inflammatory diseases in Canada
The approval of Rymti® by Health Canada underlines the scientific success of Lupin’s biosimilar programs
Biocon Biologics launches biosimilar ‘Hulio’ in USA
HULIO® (adalimumab-fkjp) injection, a biosimilar to Humira® (adalimumab) has been introduced in the United States after five years of experience in Europe and two years in Canada.
Lupin’s Rymti gets approval from Canadian regulator
Rymti is Lupin’s biosimilar etanercept approved for all indications of the reference product, Enbrel
Dr Harsh Vardhan dedicates two new scientific databases to the nation
The database on `Indian Origin Academicians’, in turn, has information on 23,472 Indian academicians and research scholars working in various countries....................